Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Launched by XIAOJUAN LI · Sep 1, 2020
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying new ways to use MRI (magnetic resonance imaging) to detect early problems in cartilage, which is the tissue that helps cushion joints. Currently, doctors mainly rely on X-rays and physical exams, which often only show advanced stages of conditions like osteoarthritis. The research aims to develop quicker and more reliable MRI techniques that can measure specific markers related to cartilage health. By improving these methods, the trial hopes to provide better tools for diagnosing and monitoring bone and joint diseases.
To participate in this study, you must be at least 18 years old, but there are different age criteria for specific groups. For example, one group includes individuals aged 18-50 who have recently suffered a complete tear of the ACL (an important ligament in the knee). However, some people may not be eligible if they have certain medical conditions, such as severe anxiety about being in MRI machines, or if they are pregnant. Participants can expect to undergo MRI scans and may also be involved in follow-up assessments to see how well the new imaging techniques work. Overall, this trial aims to help improve early detection and treatment options for cartilage-related issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Group 1
- • 1. Age \> 18
- • Group 2
- • 1. Age 18-50
- • Group 3
- • 1. Age 18-50
- • 2. Sustain an acute full ACL tear in one knee; the contralateral knee uninjured
- • 3. Undergo ACL reconstructions and standard rehabilitation
- • Group 4
- • 1. Age 18-50
- Exclusion Criteria:
- • Group 1
- • 1. Contraindication to MRI such as severe claustrophobia and implanted devices such as neurostimulators, pacemakers, aneurysm clips etc.
- • 2. Pregnancy.
- • Group 2
- • 1. Contraindication to MRI such as severe claustrophobia and implanted devices such as neurostimulators, pacemakers, aneurysm clips etc.
- • 2. Pregnancy.
- • 3. History of osteoarthritis and inflammatory arthritis
- • 4. Previous injury and/or surgery on either knee
- • Group 3
- • 1. Contraindication to MRI such as severe claustrophobia and implanted devices such as neurostimulators, pacemakers, aneurysm clips etc.
- • 2. Pregnancy.
- • 3. Inability to undergo standard pre- and post-injury/operative rehabilitation
- • Group 4
- • 1. Contraindication to MRI such as severe claustrophobia and implanted devices such as neurostimulators, pacemakers, aneurysm clips etc.
- • 2. Pregnancy.
- • 3. History of osteoarthritis and inflammatory arthritis
- • 4. Previous injury and/or surgery on either knee
About Xiaojuan Li
Xiaojuan Li is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, Xiaojuan Li collaborates with leading healthcare professionals and research institutions to design and implement rigorous clinical studies. Their approach emphasizes ethical standards, patient safety, and data integrity, ensuring that all trials contribute valuable insights to the medical community. Through a combination of strategic planning and a passion for scientific discovery, Xiaojuan Li aims to facilitate the development of groundbreaking treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Patients applied
Trial Officials
Xiaojuan Li
Principal Investigator
Director, Program for Advanced Musculoskeletal Imaging
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials